MoH withdraws Augmentin 250 mg from market

The Ministry of Health (MoH) has ordered the withdrawal of Batch No. 517999 of Augmentin 250 mg for children, made by GlaxoSmithKline (GSK), from all public and private hospitals, medical centers, clinics and pharmacies as tiny plastic pieces could mix with the medicine due to a manufacturing failure. In a statement issued today, MoH's Assistant Undersecretary for Medical Practices and Licensing Dr Amin Hussein Al Amiri said the circular issued today by the Ministry also bans further imports of the same batch and orders GSK to provide a detailed report on the withdrawal of the drug and to provide enough quantities to make up for any possible shortage. All other batches of the said product are safe for human consumption and any side effects which might develop should however be reported online to the ministry, the official said.